ABSI
Price
$4.05
Change
+$0.02 (+0.50%)
Updated
Jan 23, 03:51 PM (EDT)
Capitalization
462.87M
55 days until earnings call
BDTX
Price
$2.50
Change
-$0.12 (-4.60%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
147.69M
48 days until earnings call
Ad is loading...

ABSI vs BDTX

Header iconABSI vs BDTX Comparison
Open Charts ABSI vs BDTXBanner chart's image
Absci
Price$4.05
Change+$0.02 (+0.50%)
Volume$1.13K
Capitalization462.87M
Black Diamond Therapeutics
Price$2.50
Change-$0.12 (-4.60%)
Volume$2.5K
Capitalization147.69M
ABSI vs BDTX Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. BDTX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and BDTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (ABSI: $4.03 vs. BDTX: $2.61)
Brand notoriety: ABSI and BDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 516% vs. BDTX: 172%
Market capitalization -- ABSI: $462.87M vs. BDTX: $147.69M
ABSI [@Biotechnology] is valued at $462.87M. BDTX’s [@Biotechnology] market capitalization is $147.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileBDTX’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • BDTX’s FA Score: 1 green, 4 red.
According to our system of comparison, BDTX is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 3 TA indicator(s) are bullish while BDTX’s TA Score has 3 bullish TA indicator(s).

  • ABSI’s TA Score: 3 bullish, 3 bearish.
  • BDTX’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, BDTX is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а +40.91% price change this week, while BDTX (@Biotechnology) price change was +23.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

ABSI is expected to report earnings on May 20, 2025.

BDTX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($463M) has a higher market cap than BDTX($148M). ABSI YTD gains are higher at: 53.817 vs. BDTX (21.963). BDTX (-81.02M) and ABSI (-83.27M) have comparable annual earnings (EBITDA) . ABSI has more cash in the bank: 127M vs. BDTX (113M). ABSI has less debt than BDTX: ABSI (12M) vs BDTX (23M). ABSI has higher revenues than BDTX: ABSI (4.21M) vs BDTX (0).
ABSIBDTXABSI / BDTX
Capitalization463M148M313%
EBITDA-83.27M-81.02M103%
Gain YTD53.81721.963245%
P/E RatioN/AN/A-
Revenue4.21M0-
Total Cash127M113M112%
Total Debt12M23M52%
TECHNICAL ANALYSIS
Technical Analysis
ABSIBDTX
RSI
ODDS (%)
N/A
Bullish Trend 16 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 16 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 16 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 16 days ago
90%
Bullish Trend 16 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
87%
Bearish Trend 16 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 16 days ago
85%
Bearish Trend 16 days ago
89%
Advances
ODDS (%)
Bullish Trend 18 days ago
89%
N/A
Declines
ODDS (%)
Bearish Trend 24 days ago
90%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 16 days ago
71%
Aroon
ODDS (%)
N/A
Bearish Trend 16 days ago
86%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGJMX116.291.08
+0.94%
Fidelity Advisor Communication ServicesI
HDVIX12.320.01
+0.08%
Hartford International Equity I
SRIAX12.94N/A
N/A
Gabelli SRI A
TNRAX19.01N/A
N/A
1290 Avantis U.S. Large Cap Growth A
ACIIX8.59-0.05
-0.58%
American Century Equity Income I

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with CRSP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+25.16%
CRSP - ABSI
51%
Loosely correlated
+6.48%
BEAM - ABSI
51%
Loosely correlated
+7.58%
ABCL - ABSI
50%
Loosely correlated
+15.36%
PRME - ABSI
50%
Loosely correlated
+9.28%
RXRX - ABSI
48%
Loosely correlated
+8.87%
More